Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) announced on June 9, 2023, the completion of its previously announced acquisition of OneOncology. This significant transaction was executed through a joint venture with TPG, a global alternative asset management firm. Cencora has acquired a minority equity interest in OneOncology as part of this deal.
Key Highlights
- 1Cencora, Inc. (COR) completed the acquisition of OneOncology.
- 2The acquisition was a joint venture with TPG.
- 3Cencora acquired a minority equity interest in OneOncology.
- 4The transaction was previously announced and has now been finalized as of June 8, 2023.
- 5A press release detailing the transaction was issued on June 9, 2023, and is furnished as part of the filing.
Frequently Asked Questions
The main event is the completion of the acquisition of OneOncology by Cencora, Inc. (formerly AmerisourceBergen Corporation) in partnership with TPG.
Cencora acquired a minority equity interest in OneOncology as part of the joint venture.
TPG is a global alternative asset management firm that partnered with Cencora in a joint venture to complete the acquisition of OneOncology.
The acquisition was completed on June 8, 2023.